NasdaqGM - Delayed Quote USD
Artiva Biotherapeutics, Inc. (ARTV)
2.0000
-0.1600
(-7.41%)
At close: 4:00:00 PM EDT
2.1000
+0.10
+(5.00%)
After hours: 7:21:21 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.77 | -0.81 | -2.94 | -2.75 |
| Low Estimate | -0.77 | -0.81 | -2.94 | -2.75 |
| High Estimate | -0.77 | -0.81 | -2.94 | -2.75 |
| Year Ago EPS | -0.64 | -0.87 | -5.49 | -2.94 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | 251k | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | -100.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -1.59 | -0.63 | -0.58 | -0.62 |
| EPS Actual | -0.64 | -0.87 | -- | -0.83 |
| Difference | 0.95 | -0.24 | -- | -0.21 |
| Surprise % | 59.89% | -37.46% | -- | -33.87% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.77 | -0.81 | -2.94 | -2.75 |
| 7 Days Ago | -0.66 | -0.7 | -2.54 | -2.68 |
| 30 Days Ago | -0.66 | -0.7 | -2.54 | -2.68 |
| 60 Days Ago | 0 | 0 | -2.61 | -2.76 |
| 90 Days Ago | 0 | 0 | -2.61 | -2.76 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ARTV | -20.73% | 7.21% | 46.42% | 6.46% |
| S&P 500 | 13.32% | 2.61% | 7.73% | 13.77% |
Upgrades & Downgrades
| Maintains | Needham: Buy to Buy | 5/15/2025 |
| Reiterates | Needham: Buy to Buy | 4/8/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/26/2025 |
| Reiterates | Wedbush: Outperform to Outperform | 3/25/2025 |
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 3/25/2025 |
| Reiterates | Needham: Buy to Buy | 3/25/2025 |
Related Tickers
CTNM Contineum Therapeutics, Inc.
3.8550
+0.65%
BOLD Boundless Bio, Inc.
1.6600
0.00%
AVBP ArriVent BioPharma, Inc.
20.47
-1.87%
OKUR OnKure Therapeutics, Inc.
2.2500
-3.02%
CLYM Climb Bio, Inc.
1.2100
-2.42%
PMVP PMV Pharmaceuticals, Inc.
0.9014
-3.16%
KYTX Kyverna Therapeutics, Inc.
2.2100
-7.53%
NKTX Nkarta, Inc.
1.7000
-5.56%
RAPP Rapport Therapeutics, Inc.
10.04
-1.76%
PRLD Prelude Therapeutics Incorporated
0.9141
-6.91%